Literature DB >> 28886439

Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.

Ryuya Maekawa1, Yusuke Seino2, Hidetada Ogata1, Masatoshi Murase1, Atsushi Iida1, Kaori Hosokawa1, Erina Joo3, Norio Harada3, Shin Tsunekawa1, Yoji Hamada1, Yutaka Oiso1, Nobuya Inagaki3, Yoshitaka Hayashi4, Hiroshi Arima1.   

Abstract

Excess carbohydrate intake causes obesity in humans. On the other hand, acute administration of fructose, glucose or sucrose in experimental animals has been shown to increase the plasma concentration of anti-obesity hormones such as glucagon-like peptide 1 (GLP-1) and Fibroblast growth factor 21 (FGF21), which contribute to reducing body weight. However, the secretion and action of GLP-1 and FGF21 in mice chronically fed a high-sucrose diet has not been investigated. To address the role of anti-obesity hormones in response to increased sucrose intake, we analyzed mice fed a high-sucrose diet, a high-starch diet or a normal diet for 15 weeks. Mice fed a high-sucrose diet showed resistance to body weight gain, in comparison with mice fed a high-starch diet or control diet, due to increased energy expenditure. Plasma FGF21 levels were highest among the three groups in mice fed a high-sucrose diet, whereas no significant difference in GLP-1 levels was observed. Expression levels of uncoupling protein 1 (UCP-1), FGF receptor 1c (FGFR1c) and β-klotho (KLB) mRNA in brown adipose tissue were significantly increased in high sucrose-fed mice, suggesting increases in FGF21 sensitivity and energy expenditure. Expression of carbohydrate responsive element binding protein (ChREBP) mRNA in liver and brown adipose tissue was also increased in high sucrose-fed mice. These results indicate that FGF21 production in liver and brown adipose tissue is increased in high-sucrose diet and participates in resistance to weight gain.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ChREBP; Energy expenditure; FGF21; GLP-1; Sucrose diet

Mesh:

Substances:

Year:  2017        PMID: 28886439     DOI: 10.1016/j.jnutbio.2017.07.010

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  16 in total

1.  Ces1d deficiency protects against high-sucrose diet-induced hepatic triacylglycerol accumulation.

Authors:  Jihong Lian; Russell Watts; Ariel D Quiroga; Megan R Beggs; R Todd Alexander; Richard Lehner
Journal:  J Lipid Res       Date:  2019-02-08       Impact factor: 5.922

2.  Dietary Fat and Sugar Differentially Affect β-Adrenergic Stimulation of Cardiac ERK and AKT Pathways in C57BL/6 Male Mice Subjected to High-Calorie Feeding.

Authors:  Sadia Ashraf; Gizem Yilmaz; Xu Chen; Romain Harmancey
Journal:  J Nutr       Date:  2020-05-01       Impact factor: 4.798

Review 3.  Homeostatic sensing of dietary protein restriction: A case for FGF21.

Authors:  Cristal M Hill; Hans-Rudolf Berthoud; Heike Münzberg; Christopher D Morrison
Journal:  Front Neuroendocrinol       Date:  2018-06-08       Impact factor: 8.606

Review 4.  Brown and Brite: The Fat Soldiers in the Anti-obesity Fight.

Authors:  Shireesh Srivastava; Richard L Veech
Journal:  Front Physiol       Date:  2019-01-30       Impact factor: 4.566

5.  Influence of high fat and different types of carbohydrate diet on energy metabolism in growing mice.

Authors:  Nana Chung; Kiwon Lim
Journal:  J Exerc Nutrition Biochem       Date:  2019-09-30

Review 6.  The Role of Mondo Family Transcription Factors in Nutrient-Sensing and Obesity.

Authors:  Huiyi Ke; Yu Luan; Siming Wu; Yemin Zhu; Xuemei Tong
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-31       Impact factor: 5.555

7.  Functional adenosine triphosphate-sensitive potassium channel is required in high-carbohydrate diet-induced increase in β-cell mass.

Authors:  Masatoshi Murase; Yusuke Seino; Ryuya Maekawa; Atsushi Iida; Kaori Hosokawa; Tomohide Hayami; Shin Tsunekawa; Yoji Hamada; Norihide Yokoi; Susumu Seino; Yoshitaka Hayashi; Hiroshi Arima
Journal:  J Diabetes Investig       Date:  2018-09-04       Impact factor: 4.232

Review 8.  FGF21 and the Physiological Regulation of Macronutrient Preference.

Authors:  Cristal M Hill; Emily Qualls-Creekmore; Hans-Rudolf Berthoud; Paul Soto; Sangho Yu; David H McDougal; Heike Münzberg; Christopher D Morrison
Journal:  Endocrinology       Date:  2020-03-01       Impact factor: 4.736

Review 9.  Fibroblast Growth Factor 21 and the Adaptive Response to Nutritional Challenges.

Authors:  Úrsula Martínez-Garza; Daniel Torres-Oteros; Alex Yarritu-Gallego; Pedro F Marrero; Diego Haro; Joana Relat
Journal:  Int J Mol Sci       Date:  2019-09-21       Impact factor: 5.923

10.  Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice.

Authors:  Cuiqing Zhao; Liming Liu; Qi Liu; Fengyuan Li; Lihua Zhang; Fenxia Zhu; Tuo Shao; Shirish Barve; Yiping Chen; Xiaokun Li; Craig J McClain; Wenke Feng
Journal:  Mol Metab       Date:  2019-09-03       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.